Clozapine fails to prevent the development of haloperidol-induced behavioral hypersensitivity in a cotreatment paradigm
- 1 August 1990
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 184 (1) , 43-53
- https://doi.org/10.1016/0014-2999(90)90665-s
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Dopaminergic alterations in cotreatments attenuating haloperidol-induced hypersensitivityPharmacology Biochemistry and Behavior, 1990
- Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferationLife Sciences, 1988
- Chronic treatment with classical and atypical antipsychotic drugs differentially decreases dopamine release in striatum and nucleus accumbens in vivoNeuroscience Letters, 1987
- Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviorsEuropean Journal of Pharmacology, 1986
- The effect of antimuscarinic agents on haloperidol induced behavioral hypersensitivityEuropean Journal of Pharmacology, 1986
- Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neuronsJournal of Neuroscience, 1983
- Scopolamine induces an increase in muscarinic receptor level in rat hippocampusBrain Research, 1980
- Amantadine reduces haloperidol-induced dopamine receptor hypertensitivity in the striatumEuropean Journal of Pharmacology, 1980
- Antischizophrenic Drugs: Chronic Treatment Elevates Dopamine Receptor Binding in BrainScience, 1977
- Effect of clozapine on the turnover of dopamine in the corpus striatum and in the limbic systemJournal of Pharmacy and Pharmacology, 1973